2-(2-((2-hydroxyethyl)(methyl)amino)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione

ID: ALA4084405

PubChem CID: 137647514

Max Phase: Preclinical

Molecular Formula: C17H18N2O3

Molecular Weight: 298.34

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(CCO)CCN1C(=O)c2cccc3cccc(c23)C1=O

Standard InChI:  InChI=1S/C17H18N2O3/c1-18(10-11-20)8-9-19-16(21)13-6-2-4-12-5-3-7-14(15(12)13)17(19)22/h2-7,20H,8-11H2,1H3

Standard InChI Key:  SNZAOTGIWKKNPY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   13.0700  -15.0272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0700  -14.2059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3606  -13.7932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3606  -12.9719    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.6540  -14.2077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9500  -13.7996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2391  -14.2058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2391  -15.0284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9535  -15.4354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6540  -15.0259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3606  -15.4358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3606  -16.2468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6613  -16.6545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9535  -16.2506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7830  -13.7994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4936  -14.2101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2067  -13.8035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9141  -14.2171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6209  -13.8140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3305  -14.2264    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2067  -12.9842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7812  -15.4410    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  5  3  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
 10  9  1  0
 10  5  2  0
 11 10  1  0
 11  1  1  0
 12 11  2  0
 13 12  1  0
 14 13  2  0
  9 14  1  0
  2 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 17 21  1  0
  1 22  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4084405

    ---

Associated Targets(non-human)

CV-1 (316 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 298.34Molecular Weight (Monoisotopic): 298.1317AlogP: 1.36#Rotatable Bonds: 5
Polar Surface Area: 60.85Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.24CX LogP: 1.24CX LogD: 0.33
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.85Np Likeness Score: -0.84

References

1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A..  (2017)  Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents.,  27  (16): [PMID:28666733] [10.1016/j.bmcl.2017.06.035]

Source